Upgrade to SI Premium - Free Trial

Merck (MRK) Announces FDA Approved Two New Indications for KEYTRUDA

June 11, 2019 6:46 AM
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles